Experimental consumable for simulating penetration of tumor cells through vessel wall and use method of experimental consumable

By designing the improved Transwell chamber and precoated structure, experimental consumables that simulate tumor cells penetrating the vasculature walls, the problem that in vitro experiments in the prior art cannot effectively simulate tumor cells penetrating blood vessels and lymphatic vessels, and improve experimental efficiency and repeatability, reducing costs and time.

CN119020165APending Publication Date: 2024-11-26THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411189309.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-28
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In the prior art, in vitro tumor cell migration and invasion experiments cannot effectively simulate the process of tumor cells penetrating blood vessels and lymphatic vessels, resulting in the experiment taking a long time, inefficient and low repetition.

Method used

An experimental consumable consisting of components A and B was designed. Component A was a modified Transwell chamber. Component B had a precoated surface, which simulated tumor cells penetrating the vascular wall through the disassembly connection between component A and component B, and combined with a high transparency material. Experimental methods for precoating polylysine to ensure endothelial cell growth and tumor cell penetration ability.

Benefits of technology

It significantly improves the experimental efficiency and repeatability, shortens the experimental time, reduces economic costs, and meets the simulation requirements for the process of tumor cells entering blood vessels and lymphatic vessels.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020165A_ABST
    Figure CN119020165A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of cell experiment consumables, and discloses an experiment consumable for simulating tumor cells to penetrate through a vessel wall and a using method thereof.The consumable comprises a component A and a component B. The component A is an improved Transwell chamber composed of an insert body A and a membrane A, one end of the insert body A is open, the insert body A is in an inverted frustum shape, and the membrane A is arranged at the bottom of the insert body A; the component B is composed of a plug-in main body B with two open ends and a membrane B which divides an inner cavity of the plug-in main body B into two experiment cavities, a pre-coating is arranged on one side of the membrane B, the plug-in main body A is detachably inserted into the experiment cavity of the plug-in main body B, and the plug-in main body A is matched with the experiment cavity of the plug-in main body B. According to the method, the defect that the conventional in-vitro tumor cell migration and invasion experiment cannot finish analogue simulation of the process that tumor cells enter blood vessels and lymphatic vessels is overcome, the efficiency and repeatability are greatly improved, the time and economic cost is reduced, and good social and economic benefits are achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of cell experiment consumables, and in particular to an experiment consumable for simulating tumor cells penetrating a vascular wall and a use method thereof. Background Art

[0002] Most researchers choose to observe the lymphatic and vascular metastasis of tumors through animal experiments to evaluate the ability of tumor cells to enter blood vessels and lymphatic vessels. However, this experiment requires the use of pre-labeled cells, the construction of xenograft tumors, and the observation of tumor metastasis. Finally, special means are used to detect the number of circulating tumor cells. This takes 2-3 months and is often used as the final verification stage of the study. In the screening process to determine specific key molecules, exploring new in vitro experimental methods and corresponding consumables that are conducive to batch processing is not only an experimental alternative based on the 3R principles of animal welfare, but also a necessary step and means to significantly shorten the experimental time, facilitate later data analysis and processing, and reduce experimental costs. In addition, the selection of reliable and reasonable in vitro experimental consumables can simplify the experimental steps and links as much as possible to avoid errors, providing a guarantee for the repeatability of the experiment.

[0003] In the process of tumors entering blood vessels and lymphatic vessels, on the one hand, the extracellular matrix needs to be hydrolyzed, and on the other hand, the cell membrane, cytoskeleton and nuclear deformation required to destroy the tight junctions between endothelial cells and penetrate the intercellular space are also required. Therefore, the most basic wall penetration process model needs to reflect the penetration of the extracellular matrix and at least simulate the penetration process of vascular endothelial / lymphatic endothelial cells. Among the commonly used in vitro experiments, the migration experiment of the cell chamber only evaluates the ability of cells to pass through the small holes, and although the invasion experiment adds matrix gel to simulate the extracellular matrix, neither of them can evaluate the process of cells penetrating the tightly connected monolayer endothelial cells.

[0004] Through the above analysis, the problems and defects of the existing technology are as follows: in the experimental methods for evaluating the ability of tumor cells to pass through blood vessels and lymphatic vessels, animal experiments are time-consuming and costly and are mostly used to verify the experimental results. The existing conventional in vitro invasion experiments only simulate the process of tumor cells penetrating the matrix and pores, and it is difficult to reflect the process of cells penetrating the vascular / lymphatic endothelium, and therefore cannot meet the purpose and needs of the experiment.

[0005] Although conventional migration and invasion experiments do not require consideration of how to lay endothelial cells and fix them on the path of the tumor's movement to the high serum culture environment, the two types of experiments require a chamber with an internal volume of 300ul to conduct the experiment. However, the bottom diameter is less than 0.7cm, and even if the cell suspension is coated on the bottom surface, it cannot guarantee growth. Therefore, endothelial cells cannot be laid on the other side of the chamber membrane, and the in vitro experimental steps of simulating the process of tumor cells crossing the extracellular matrix-endothelial cells cannot be completed efficiently, and the repeatability is low.

[0006] At present, there are no directly applicable corresponding experimental consumables that can reflect the vascular invasion ability. Although some of the currently published literature mentions the physiological process that the experiment intends to simulate, there is no specific description of the experimental operation steps, that is, the implementation method, nor is there any consumable other than the conventional Transwell chamber. Therefore, how to achieve the laying of endothelium on the back of the chamber still needs to be explored by yourself. The Chinese patent with application number CN202110526358.8 discloses a Transwell chamber for simulating cell intravasation and a method of use. The consumable is made by using hot-melt Transwell chambers and splicing them in pairs. This modification process is artificial, which causes the experimental process to be subject to the experience and skill proficiency of the experimenter, so there are disadvantages that the experiment is time-consuming, inefficient and not highly repeatable.

[0007] Therefore, the present application designs an experimental consumable that can make up for the fact that conventional in vitro tumor cell migration and invasion experiments cannot complete the simulation of the process of tumor cells entering blood vessels and lymphatic vessels. It can completely simulate the walls of blood vessels or lymphatic vessels, thereby greatly improving efficiency and having extremely high repeatability. Summary of the invention

[0008] The present invention aims to provide an experimental consumable for simulating tumor cells penetrating through vascular walls and a method of using the same, which can be used in conjunction with a modified Transwell chamber for endothelial cell laying to solve the shortcomings of the prior art that conventional in vitro tumor cell migration and invasion experiments cannot be compensated, and thus the simulation of the process of tumor cells entering blood vessels and lymphatic vessels cannot be completed, resulting in technical problems such as time-consuming, inefficient and low repeatability experiments.

[0009] In order to achieve the above object, the present invention provides the following technical solutions:

[0010] An experimental consumable for simulating tumor cells penetrating a vascular wall, comprising a component A and a component B, wherein the component A is a modified Transwell chamber consisting of a plug-in body A with an opening at one end and in the shape of an inverted frustum and a membrane A arranged at the bottom of the plug-in body A, wherein the plug-in body A has a cavity for experiments inside; the component B is composed of a plug-in body B with openings at both ends and a membrane B that divides the internal cavity of the plug-in body B into two completely identical experimental chambers, wherein the longitudinal section of the plug-in body B is two symmetrical trapezoids, one side of the membrane B is provided with a pre-coating, the plug-in body A can be detachably inserted into the experimental chamber of the plug-in body B, and the plug-in body A is adapted to the experimental chamber of the plug-in body B.

[0011] Preferably, the membrane A and membrane B are both expanded polytetrafluoroethylene membranes, the membrane A structure needs to be treated with cell TC culture to facilitate the attachment and growth of tumor cells, and the pre-coating is made of polylysine, so that membrane B is conducive to the attachment and growth of endothelial cells.

[0012] Preferably, the height of the component A is 13 mm, the top outer diameter is 18.6 mm, the bottom outer diameter is 6.5 mm, and the pore size of the membrane A is 8 um.

[0013] Preferably, the membrane B has a diameter of 6.5 mm, a thickness of 50 um, a pore size of 8 um, and a distance between the membrane B and the pre-coating of 20-40 um.

[0014] Preferably, the plug-in body A and the plug-in body B are both made of high-transparency crystalline polystyrene and do not need to be subjected to cell TC culture treatment.

[0015] Preferably, the components A and B are separately packaged after being irradiated or sterilized with ethylene oxide, and the total height of the components A and B after being assembled is 16 mm.

[0016] The present invention also provides a method for using an experimental consumable for simulating tumor cells penetrating a vascular wall, comprising the following steps:

[0017] S1. Take out component B and place it in a conventional cell culture 24-well plate, with the non-pre-coated surface facing upwards, and drip the matrix gel working solution into the experimental chamber of the plug-in body B and wait for it to solidify;

[0018] S2, flip component B and place it in a 24-well plate so that the side coated with poly-lysine faces upward, drop endothelial cell suspension into another experimental chamber of component B for culture, discard the culture medium after overnight culture, and add culture medium containing 10% fetal bovine serum again;

[0019] S3, take out component A, pre-lay fluorescent dye-labeled tumor cells in the cavity of the modified Transwell chamber, gently press to fasten component A with any experimental chamber of component B, and continue to culture for 8-24 hours;

[0020] S4. After the experiment, disassemble component A and component B, use a sterile sharp blade to cut off the membrane B part of component B, place it on a slide, observe and count the tumor cells under a fluorescence microscope, or use the fluorescence microscope scanning mode to directly capture the whole image for further analysis.

[0021] Preferably, in step S1, the bottom diameter of the conventional cell culture 24-well plate is 16 mm, and the height inside the well is 18 mm; the matrix gel working solution is a 1:39 diluted matrix gel solution, and the added amount of the matrix gel working solution is 100 ul.

[0022] Preferably, in step S2, the amount of endothelial cell suspension added is 150-200ul, and the endothelial cell suspension is cultured specifically by adding 575ul of complete culture medium to a 24-well plate, covering the 24-well plate with a lid, and culturing in a cell culture incubator overnight; the liquid levels of the complete culture medium and the culture medium containing 10% fetal bovine serum are both flush with the surface of membrane B in component B.

[0023] Preferably, in step S3, the gentle pressure applied to fasten the component to any experimental chamber of component B is specifically selected according to the process of tumor cells entering / exiting the blood vessels that the user intends to simulate; when the side of component B coated with matrix gel is selected to be close to component A, the process of tumor cells entering the blood vessels is simulated, and when the side covered with endothelium is selected to be close to component A, the process of tumor cells infiltrating the blood vessels and colonizing the target organs is simulated.

[0024] Compared with the prior art, the present invention has the following beneficial effects:

[0025] 1. The bottom diameter of a conventional cell culture 24-well plate is 16 mm, and the height inside the well is 18 mm, while the top outer diameter of component A in the present application is 18.6 mm, which is suitable for a general 24-well plate of current standard specifications (no TC treatment is required), so that the top outer diameter of component A is suspended on the 24-well wall, and its bottom does not contact the bottom of the well of the 24-well plate; the total height of component A and component B after assembly is 16 mm, so that there is at least 2 mm space between the bottom of component B and the bottom of the well of the 24-well plate, ensuring that after the cells and matrix gel are laid during the experiment, the assembly of component A and component B can be fully immersed in the culture medium, and the connection between component A and component B will not be displaced as the 24-well plate is moved (such as placed in a cell culture incubator).

[0026] 2. Component A and component B are detachably connected by snaps. On the one hand, the separate irradiation sterilization packaging of the two is conducive to the cultivation of tumor cells and endothelial cells respectively, and the process has no operational threshold; on the other hand, component A and component B are connected by the toughness of their own materials and can be disassembled after the experiment. At this time, only the tumor cells on the uncoated lysine surface of component B need to be observed to analyze the ability of tumor cells to pass through the matrix and endothelial cells, that is, the ability of tumor cells to enter blood vessels / lymphatic vessels; while the traditional Transwell chamber needs to be flipped when conducting experiments, and endothelial cell suspension is dripped on its bottom membrane. The cell suspension cannot exceed 50ul, and the endothelial cell growth fusion can only be estimated based on the preliminary experiment. When the fusion reaches 85% or more, the Transwell chamber can be flipped over and placed in a 24-well plate for the next step of tumor cell laying. Therefore, the experimental consumables of the present invention can greatly shorten the experimental time and improve the experimental efficiency.

[0027] 3. By designing a consumable that can completely simulate the walls of blood vessels or lymphatic vessels, it can make up for the fact that conventional in vitro tumor cell migration and invasion experiments cannot complete the simulation of the process of tumor cells entering blood vessels and lymphatic vessels, which can greatly improve efficiency and repeatability. It is a direct reflection of Replacement in the 3R principle of animal welfare, reduces time and economic costs, and also greatly reduces the experimental threshold for a comprehensive assessment of tumor metastasis potential, which has good social and economic benefits. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 Schematic diagram of the structure of the experimental consumables in the embodiment of the present invention (A is component A, B is component B, and C is the assembly of component A and component B);

[0029] Figure 2 A schematic diagram illustrating a method for using the experimental consumables in an embodiment of the present invention;

[0030] Figure 3 A flowchart of a method for using experimental consumables in an embodiment of the present invention;

[0031] In the figure: 1. Plug-in body A; 2. Membrane A; 3. Plug-in body B; 4. Membrane B; 5. Pre-coating. DETAILED DESCRIPTION

[0032] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.

[0033] The present invention provides an experimental consumable for simulating tumor cells penetrating a vascular wall, comprising a component A and a component B. Component A is a modified Transwell chamber composed of a plug-in body A1 with an opening at one end and in an inverted frustum shape and a membrane A2 arranged at the bottom of the plug-in body A1, wherein the plug-in body A1 has a cavity for experiments inside; component B is composed of a plug-in body B3 with openings at both ends and a membrane B4 that divides the internal cavity of the plug-in body B3 into two completely identical experimental chambers, wherein the longitudinal section of the plug-in body B3 is two symmetrical trapezoids, one side of the membrane B4 is provided with a pre-coating 5, the plug-in body A1 can be detachably plugged into the experimental chamber of the plug-in body B3, and the plug-in body A1 is adapted to the experimental chamber of the plug-in body B3.

[0034] Preferably, membrane A2 and membrane B4 are both expanded polytetrafluoroethylene membranes, the membrane A2 structure needs to be treated with cell TC culture to facilitate the attachment and growth of tumor cells, and the pre-coating 5 is made of poly-lysine, so that membrane B4 is conducive to the attachment and growth of endothelial cells.

[0035] Preferably, the height of component A is 13 mm, the top outer diameter is 18.6 mm, the bottom outer diameter is 6.5 mm, and the pore size of membrane A2 is 8 um.

[0036] Preferably, the membrane B4 has a diameter of 6.5 mm, a thickness of 50 um, a pore size of 8 um, and a distance between the membrane B4 and the pre-coating 5 of 20-40 um.

[0037] Preferably, both the plug-in body A1 and the plug-in body B3 are made of high-transparency crystalline polystyrene and do not need to be subjected to cell TC culture treatment.

[0038] Preferably, component A and component B are separately packaged after being irradiated or sterilized with ethylene oxide, and the total height of component A and component B after assembly is 16 mm.

[0039] The present invention also provides a method for using an experimental consumable for simulating tumor cell intravasation, comprising the following steps:

[0040] S1. Take out component B and place it in a 24-well plate for conventional cell culture, with the non-pre-coated surface facing upward, and drip the matrix gel working solution into the experimental chamber of the plug-in body B3 and wait for it to solidify;

[0041] S2, flip component B and place it in a 24-well plate so that the side coated with poly-lysine faces upward, drop endothelial cell suspension into another experimental chamber of the plug-in body B3 for culture, discard the culture medium after overnight culture, and add culture medium containing 10% fetal bovine serum again;

[0042] S3, take out component A, pre-lay fluorescent dye-labeled tumor cells in the cavity of the modified Transwell chamber, gently press to fasten component A with any experimental chamber of component B, and continue to culture for 8-24 hours;

[0043] S4. After the experiment, disassemble component A and component B, use a sterile sharp blade to cut off the membrane B4 part of component B, place it on a slide, observe and count the tumor cells under a fluorescence microscope, or use the fluorescence microscope scanning mode to directly capture the whole image for further analysis.

[0044] Preferably, in step S1, the bottom diameter of the conventional cell culture 24-well plate is 16 mm, and the height inside the well is 18 mm; the matrix gel working solution is a 1:39 diluted matrix gel solution, and the added amount of the matrix gel working solution is 100 ul.

[0045] Preferably, in step S2, the amount of endothelial cell suspension added is 150-200ul, and the endothelial cell suspension is cultured specifically by adding 575ul of complete culture medium to a 24-well plate, covering the 24-well plate with a lid, and culturing in a cell culture incubator overnight. The liquid levels of the complete culture medium and the culture medium containing 10% fetal bovine serum are both flush with the surface of membrane B4 in component B.

[0046] Preferably, in step S3, the gentle pressure applied to fasten the component to any experimental chamber of component B is specifically selected according to the process of tumor cells entering / exiting the blood vessels that the user intends to simulate. When the side of component B coated with matrix gel is placed close to component A, the process of tumor cells entering the blood vessels is simulated, and when the side covered with endothelium is placed close to component A, the process of tumor cells infiltrating the blood vessels and colonizing the target organs is simulated.

[0047] Example

[0048] The experimental consumables designed by the present invention are used in an experiment simulating tumor cells penetrating a vascular wall, comprising the following steps:

[0049] S1. Take out component B and place it in a 24-well plate for conventional cell culture, wherein the bottom diameter of the conventional cell culture 24-well plate is 16 mm and the height of the well is 18 mm. Place component B with the non-pre-coated 5 side facing up, add 100 ul of Matrigel working solution into the experimental chamber, and let it stand at room temperature for 1 hour to solidify; wherein the Matrigel working solution is a Matrigel solution diluted at 1:39;

[0050] S2. Turn over component B and place it in a 24-well plate so that the side coated with poly-lysine faces upwards. Add 150-200ul (the user can flexibly adjust the specific amount of addition according to the cell status, cell density and planned culture time) of endothelial cell suspension in the experimental chamber, and add 575ul of complete culture medium to the 24-well plate. At this time, the liquid surface in the wells of the 24-well plate is flush with the plane of membrane B4 in component B. Cover the 24-well plate with a lid and place it in a cell culture incubator for culture overnight. The state and fullness of the endothelial cells can be observed under a light microscope the next day. If the growth state of the endothelial cells is satisfactory, discard the culture medium in the 24-well plate and add culture medium containing 10% fetal bovine serum again to make it flush with the surface of membrane B4 in component B.

[0051] S3. First, use sterile tweezers to pick up the plug-in body B3 in the 24-well plate and place it in a culture dish (can be used with a diameter of 6 cm or more). Then take out component A, align it with component B, and gently press it to clamp any experimental chamber of component A and component B. Put it back into the 24-well plate, digest, centrifuge, resuspend and count the tumor cells labeled with fluorescent dye, drop the tumor cell suspension into plug-in A, add 600ul complete culture medium to the well plate, continue to culture for the predetermined time, disassemble plug-ins A and B, cut off the plug with a sharp blade, and then remove the plug-in body. The membrane B4 (ePTFE membrane) on the component body B3 is placed on a coverslip, so that the ability of tumor cells to pass through the extravascular matrix and endothelial cells of blood vessels / lymphatic vessels can be observed, counted and analyzed. It should be noted here that in this step, the user selects component A to insert into an experimental chamber of component B according to the intended process of tumor cells entering and exiting the blood vessels; the side coated with matrix gel is placed close to component A to simulate the process of entering the blood vessels, and the side covered with endothelium is placed close to component A to simulate the process of exuding blood vessels and colonizing target organs.

[0052] S4. After the experiment, disassemble component A and component B, use a sterile sharp blade to cut off the membrane B4 part of component B, place it on a slide, observe and count the tumor cells under a fluorescence microscope, or use the fluorescence microscope scanning mode to directly capture the whole image for further analysis.

[0053] Comparative Example 1

[0054] Conventional Transwell chambers were used to simulate the experiment of tumor cells penetrating the cell wall. The specific steps are as follows: turn the commercially available Transwell chamber over and place it in a culture dish, digest, centrifuge, and resuspend the endothelial cells, drop the endothelial cell suspension on the back of the membrane at the bottom of the Transwell chamber, and place it in a cell culture incubator for overnight incubation (depending on the cell density and proliferation status, usually 16-24 hours). Use sterile tweezers to pick up the chamber, turn it over and place it in a 24-well plate, dilute Matrigel (matrigel) 1:39, drop 100ul in the chamber, and let it stand at room temperature for 1 hour. After the matrix gel solidifies, drop the digested, centrifuged, resuspended and counted tumor cell suspension in the chamber, and add complete culture medium to the 24-well plate. Incubate in a 37°C cell culture incubator for 24 hours, take out the chamber, gently wipe off the matrix gel inside it and the tumor cells that have not passed through the small holes on the membrane, and observe and count them.

[0055] The operational difficulty of the experimental process in Comparative Example 1 is that the membrane area of ​​the conventional Transwell chamber is only 0.33cm3, which is difficult to carry more than 50ul of liquid. Once the liquid containing endothelial cells diffuses, it cannot be remedied. Unlike coated collagen or fibronectin, or polylysine, laying endothelial cells requires that the liquid can stably stay on the membrane surface and can retain a sufficient amount to maintain endothelial growth (coated protein or polylysine only needs to be evenly coated and wait for it to dry). Currently available Transwell chambers do not have a matching inverted culture device, so the endothelial cells are cultured and the bottom of the droplet has no contact with the liquid culture medium. During the overnight culture of endothelial cells, liquid often penetrates into the chamber through the small holes with a diameter of 8 microns on the membrane. Although endothelial cells still remain on the membrane surface, the cells cannot grow after drying. Therefore, the difficulty of this experiment is how to successfully lay endothelial cells.

[0056] Comparative Example 2

[0057] A method for using a Transwell chamber plug for simulating cell penetration through a vascular wall comprises the following steps:

[0058] S101, chamber A faces upward, Matrigel is evenly spread in chamber A and left to solidify at 37°C to simulate the extracellular matrix of blood vessels or lymphatic vessels;

[0059] S102, after Matrigel solidifies, turn the chamber over in the clean bench, with chamber B facing upward, and evenly place endothelial cells;

[0060] S103, placing in a sterile sealed container, placing in a cell culture incubator and culturing overnight, when the endothelial cell confluence exceeds 90%, taking out the model chamber, splitting it into two independent chambers, and discarding chamber B;

[0061] S104, place chamber A in a conventional 24-well cell culture plate, add full serum culture medium to the well plate, and add tumor cells diluted with serum-free culture medium to chamber A, so as to simulate the process of tumor cells passing through the matrix and endothelium in turn when entering the lymph or blood vessels.

[0062] The technical solution in Comparative Example 2 is to use two Transwell chambers to connect and then lay endothelial cells, but based on the premise of aseptic operation, there is currently no method to stably and sterilely connect two Transwell chambers. This technical solution is pasted to the bottom of another chamber after melting the side of part of the chamber at high temperature, but the success rate is very low and the repeatability is poor. On the one hand, the deformation of the melting chamber will greatly reduce the volume of the chamber, although it is easier than directly dripping the endothelial cell suspension, but it still cannot meet the conditions for observing the cell state in real time and stably providing endothelial cell growth. On the other hand, the connection support provided by the melting chamber is insufficient, and the two are often separated automatically during the endothelial cell culture process, so a large number of Transwell chambers need to be prepared, which seriously increases the experimental cost and labor cost. Third, in the process of the melting chamber adhering to another intact chamber, due to the high temperature and the high dependence of timing control on personal experience, the melted side wall will randomly destroy the bottom membrane of the intact chamber, so it is necessary to select a combination chamber with a similar membrane retention area for experiment in the experiment, and the repeatability is very poor.

[0063] When the supporting consumables designed by the present invention are used, there is no operating threshold other than cell culture for the experimental operator. The accessories are suitable for the 24-well plate commonly used in laboratories, which not only saves the amount of cells and matrix glue used, but also does not require the experimenter to perform any manual modification, thereby ensuring that the amount of tumor cells passing through the matrix glue, the density and number of endothelial cells are all at a unified standard, the consistency between and within groups is high, and the experimental repeatability is good, which is conducive to promoting the experimental method for detecting the potential of tumor cell hematogenous metastasis and lymph node metastasis, and reducing the consumption of experimental animals and experimental time.

[0064] In summary, the present invention designs a consumable that can completely simulate the walls of blood vessels or lymphatic vessels, which can make up for the simulation of the process of tumor cells entering blood vessels and lymphatic vessels that cannot be completed in conventional in vitro tumor cell migration and invasion experiments. It can greatly improve efficiency and repeatability, and is a direct embodiment of Replacement in the 3R principle of animal welfare. It reduces time and economic costs while also greatly reducing the experimental threshold for a comprehensive assessment of tumor metastasis potential, and has good social and economic benefits.

[0065] The above is only an embodiment of the present invention, and the common knowledge such as the known specific technical solutions or characteristics in the solution is not described in detail here. It should be pointed out that for those skilled in the art, several modifications and improvements can be made without departing from the technical solution of the present invention, which should also be regarded as the protection scope of the present invention, and these will not affect the effect of the implementation of the present invention and the practicality of the patent. The scope of protection required by this application shall be based on the content of its claims, and the specific implementation methods and other records in the specification can be used to interpret the content of the claims.

Claims

1. An experimental consumable for simulating tumor cells penetrating a vascular wall, comprising component A and component B, It is characterized in that The component A is a modified Transwell chamber consisting of a plug-in body A (1) with an opening at one end and in the shape of an inverted cone and a membrane A (2) arranged at the bottom of the plug-in body A (1), wherein the plug-in body A (1) has a cavity for experiments inside; the component B is composed of a plug-in body B (3) with openings at both ends and a membrane B (4) that divides the internal cavity of the plug-in body B (3) into two completely identical experimental chambers, wherein the longitudinal section of the plug-in body B (3) is two symmetrical trapezoids, and one side of the membrane B (4) is provided with a pre-coating (5), and the plug-in body A (1) can be detachably inserted into the experimental chamber of the plug-in body B (3), and the plug-in body A (1) is compatible with the experimental chamber of the plug-in body B (3).

2. An experimental consumable for simulating tumor cells penetrating a vascular wall according to claim 1, It is characterized in that The membrane A (2) and membrane B (4) are both expanded polytetrafluoroethylene membranes. The structure of the membrane A (2) needs to be treated with cell TC culture, and the pre-coating (5) is made of polylysine.

3. An experimental consumable for simulating tumor cells penetrating a vascular wall according to claim 2, It is characterized in that The height of the component A is 13 mm, the top outer diameter is 18.6 mm, the bottom outer diameter is 6.5 mm, and the pore size of the membrane A (2) is 8 um.

4. The experimental consumable material for simulating tumor cells penetrating a vascular wall according to claim 2, It is characterized in that The membrane B (4) has a diameter of 6.5 mm, a thickness of 50 um, a pore size of 8 um, and a distance between the membrane B (4) and the pre-coating (5) of 20-40 um.

5. The experimental consumable material for simulating tumor cells penetrating a vascular wall according to claim 1, It is characterized in that The plug-in body A (1) and the plug-in body B (3) are both made of high-transparency crystalline polystyrene.

6. The experimental consumable material for simulating tumor cells penetrating a vascular wall according to claim 1, It is characterized in that The components A and B are separately packaged after being irradiated or sterilized with ethylene oxide, and the total height of the components A and B after being assembled is 16 mm.

7. A method for using the experimental consumable for simulating tumor cells penetrating a vascular wall as claimed in any one of claims 1 to 6, It is characterized in that The steps include: S1. Take out component B and place it in a conventional cell culture 24-well plate, with the non-pre-coated (5) side facing upwards, and drip the matrix gel working solution into the experimental chamber of the plug-in body B (3) and wait for it to solidify; S2, flip component B and place it in a 24-well plate so that the side coated with poly-lysine faces upward, drop endothelial cell suspension into another experimental chamber of component B for culture, discard the culture medium after overnight culture, and add culture medium containing 10% fetal bovine serum again; S3, take out component A, pre-lay fluorescent dye-labeled tumor cells in the cavity of the modified Transwell chamber, gently press to fasten component A with any experimental chamber of component B, and continue to culture for 8-24 hours; S4. After the experiment, disassemble component A and component B, use a sterile sharp blade to cut off the membrane B (4) part of component B, place it on a slide, and observe and count the tumor cells under a fluorescence microscope, or use the fluorescence microscope scanning mode to directly capture the whole image for further analysis.

8. A method for using the experimental consumable for simulating tumor cells penetrating a vascular wall as claimed in claim 7, It is characterized in that In step S1, the bottom diameter of the conventional cell culture 24-well plate is 16 mm, and the height inside the well is 18 mm; the matrix gel working solution is a matrix gel solution diluted 1:39, and the addition amount of the matrix gel working solution is 100 ul.

9. A method for using the experimental consumable for simulating tumor cells penetrating a vascular wall as claimed in claim 7, It is characterized in that In step S2, the amount of endothelial cell suspension added is 150-200ul, and the endothelial cell suspension is cultured specifically by adding 575ul of complete culture medium to a 24-well plate, covering the 24-well plate with a lid, and culturing in a cell culture incubator overnight; the liquid levels of the complete culture medium and the culture medium containing 10% fetal bovine serum are both flush with the surface of membrane B (4) in component B.

10. A method for using the experimental consumables for simulating tumor cells penetrating a vascular wall as claimed in claim 7, It is characterized in that In step S3, the gentle pressure applied to fasten the component to any experimental chamber of component B is specifically selected according to the process of tumor cells entering / exiting the blood vessels that the user intends to simulate; when the side of component B coated with matrix gel is placed close to component A, the process of tumor cells entering the blood vessels is simulated, and when the side covered with endothelial cells is placed close to component A, the process of tumor cells penetrating the blood vessel wall and colonizing the target organ is simulated.